AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$621M |
| 2 |
Visa
V
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$542M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$525M |
| 5 |
Amazon
AMZN
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$693M |
| 2 |
Texas Instruments
TXN
|
+$477M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$235M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 14.87% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Financials | 12.61% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Thomson Reuters
TRI
$46.8B
| $1.71M | ﹤0.01% |
14,654
-67
| -0.5% | -$7.81K |
|
2252
Universal Corp
UVV
$1.37B
| $1.71M | ﹤0.01% |
35,284
+85
| +0.2% | +$4.31K |
|
2253
Benchmark Electronics
BHE
$2.59B
| $1.7M | ﹤0.01% |
63,756
-5,350
| -8% | -$142K |
|
2254
Enova International
ENVA
$6.18B
| $1.7M | ﹤0.01% |
49,112
-501
| -1% | -$16.3K |
|
2255
Astec Industries
ASTE
$1.2B
| $1.7M | ﹤0.01% |
31,527
+1,820
| +6% | +$107K |
|
2256
CTS Corp
CTS
$1.8B
| $1.68M | ﹤0.01% |
54,416
+3,560
| +7% | +$122K |
|
2257
Stride
LRN
$4.13B
| $1.68M | ﹤0.01% |
46,684
| – | – |
|
2258
CoreCivic
CXW
$3B
| $1.68M | ﹤0.01% |
188,260
-14,090
| -7% | -$137K |
|
|
TVTY
2259
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.68M | ﹤0.01% |
72,685
-4,300
| -6% | -$102K |
|
2260
Quanterix
QTRX
$162M
| $1.67M | ﹤0.01% |
33,600
| – | – |
|
2261
Amphastar Pharmaceuticals
AMPH
$904M
| $1.67M | ﹤0.01% |
87,935
+40,265
| +84% | +$789K |
|
|
VRTV
2262
DELISTED
VERITIV CORPORATION
VRTV
| $1.67M | ﹤0.01% |
18,657
+1,430
| +8% | +$109K |
|
|
ISEE
2263
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.67M | ﹤0.01% |
102,500
+16,200
| +19% | +$176K |
|
2264
Vanguard Total International Stock ETF
VXUS
$151B
| $1.66M | ﹤0.01% |
26,259
+2,359
| +10% | +$154K |
|
2265
Mativ Holdings
MATV
$472M
| $1.65M | ﹤0.01% |
47,683
-1,470
| -3% | -$54.9K |
|
2266
Adaptive Biotechnologies
ADPT
$3.53B
| $1.65M | ﹤0.01% |
48,536
-862
| -2% | -$31.2K |
|
2267
Huron Consulting
HURN
$2.62B
| $1.65M | ﹤0.01% |
31,700
| – | – |
|
2268
Gevo
GEVO
$348M
| $1.65M | ﹤0.01% |
247,998
+4,827
| +2% | +$29.9K |
|
2269
Castle Biosciences
CSTL
$732M
| $1.64M | ﹤0.01% |
24,700
-600
| -2% | -$42.2K |
|
2270
Customers Bancorp
CUBI
$2.68B
| $1.64M | ﹤0.01% |
38,120
-1,350
| -3% | -$52.5K |
|
|
CLVS
2271
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.63M | ﹤0.01% |
365,800
+146,900
| +67% | +$708K |
|
2272
Impinj
PI
$4.04B
| $1.63M | ﹤0.01% |
28,501
+9,301
| +48% | +$475K |
|
2273
Peabody Energy
BTU
$2.54B
| $1.63M | ﹤0.01% |
110,000
-23,700
| -18% | -$310K |
|
2274
Brookdale Senior Living
BKD
$3.6B
| $1.63M | ﹤0.01% |
258,114
+3,940
| +2% | +$28.1K |
|
2275
Innovator US Equity Power Buffer ETF December
PDEC
$975M
| $1.62M | ﹤0.01% |
52,598
-69,921
| -57% | -$2.15M |
|
Similar funds
AllianceBernstein's Q3 2021 Portfolio in Review
As of Q3 2021, AllianceBernstein held 3,430 positions worth $253B, up 1.8% from $249B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AllianceBernstein's Q3 2021 filing shows 114 new, 1,102 increased, 1,623 reduced and 152 closed positions. Its largest new stake was Freshworks: 2,094,708 shares worth $89.4M. The largest sale was Alphabet (Google) Class C, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q3 2021 buy was Freshworks: 2,094,708 shares worth $89.4M.
- AllianceBernstein added most to Qualcomm in Q3 2021, an estimated $621M increase.
- AllianceBernstein's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $693M.
- AllianceBernstein fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $230M.
- AllianceBernstein's ten largest holdings make up 25% of its $253B portfolio in Q3 2021.
- AllianceBernstein opened 114 new positions and closed 152 in Q3 2021.
- AllianceBernstein's portfolio value rose 1.8% quarter-over-quarter to $253B.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.